KIRCIK, L.; LEBWOHL, M.; PAPP, K.; GOODERHAM, M.; STEIN GOLD, L.; DRAELOS, Z.; KEMPERS, S.; TYRING, S.; ALBRECHT, L.; WISEMAN, M.; FERRIS, L.; SMITH, K.; HIGHAM, R.; NAVALE, L.; WELGUS, H.; BERK, D. Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s70, 2020. DOI: 10.25251/skin.4.supp.70. Disponível em: Acesso em: 15 aug. 2022.